¼¼°èÀÇ °­¹ÚÀå¾Ö ½ÃÀå º¸°í¼­(2025³â)
Obsessive-Compulsive Disorder Global Market Report 2025
»óǰÄÚµå : 1717259
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,265,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,056,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,846,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°­¹ÚÀå¾Ö(OCD) ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ 8.38%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 9¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ Áß OCDÀÇ À¯º´·ü Áõ°¡, ºñó¹æ ¾à¹° ¹× Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇコÄÉ¾î ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÀÎ½Ä Á¦°í Ä·ÆäÀÎ Áõ°¡, Á¤ºÎ ±¸»ó °­È­ µîÀÌ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ±â°£ Áß ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, µðÁöÅÐ Çコ ÅøÀÇ ÅëÇÕ, Ä¡·á¿¡¼­ÀÇ °¡»óÇö½Ç Ȱ¿ë, ¿ø°ÝÀÇ·á ¼­ºñ½º È®´ë, ÀÎÁö Çൿ Ä¡·áÀÇ Áö¼ÓÀûÀΠäÅà µîÀÌ ÀÖ½À´Ï´Ù.

Á¤½ÅÁúȯÀÇ À¯º´·ü Áõ°¡´Â °­¹ÚÀå¾Ö(OCD) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¤½ÅÁúȯÀº ±âºÐ, »ç°í, Çൿ, Àü¹ÝÀûÀÎ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±¤¹üÀ§ÇÑ Áõ»óÀ» Æ÷ÇÔÇϸç, OCD Áõ°¡´Â Àνİú Áø´ÜÀÇ Çâ»ó, ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­, ¸¸¼º ½ºÆ®·¹½º, ¼¼°è À§±â, »çȸÀû, °æÁ¦Àû, ȯ°æÀû ¾Ð·Â Áõ°¡¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. Á¤½ÅÁúȯÀÇ Á¶»ç, Áø´Ü, Ä¡·á¹ýÀ» ¹ßÀü½Ã۴µ¥ Áß½ÉÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 9¿ù ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)Àº 2022³â ¹Ì±¹ ¼ºÀÎÀÇ 5,930¸¸ ¸í(Àα¸ÀÇ 23.1%)ÀÌ AMI(Any Mental Illness)¸¦ °æÇèÇÒ °ÍÀ̸ç, ³²¼º(19.7%)¿¡ ºñÇØ ¿©¼º(26.4%)ÀÇ À¯º´·üÀÌ ´õ ³ôÀ» °ÍÀ̶ó°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ À¯º´·ü Áõ°¡´Â OCD °ü·Ã Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ °­Á¶ÇÏ¸ç ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

OCD ½ÃÀå¿¡ ÁøÃâÇÑ ±â¾÷Àº º¸´Ù È¿°úÀûÀÎ Ä¡·á¹ýÀ» Á¦°øÇϱâ À§ÇØ Á¤½Å°Ç°­ Ä¡·á¹ýÀ» Çõ½ÅÇϰí ÀÖ½À´Ï´Ù. 2023³â 10¿ù ´ºÆ÷Æ® ÇコÄɾî(Newport Healthcare)´Â 10-20´ë û¼Ò³âÀ» À§ÇÑ OCD Ä¡·á ÇÁ·Î±×·¥À» ¹ßÇ¥Çϸç OCD ¹× °ü·Ã Àå¾Ö¸¦ ¾Î°í Àִ û¼Ò³âÀÇ ¹ß´Þ°ú ½É¸®Àû ¾ÈÁ¤À» À§ÇØ OCD Ä¡·á ÇÁ·Î±×·¥À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥Àº OCD ¹× °ü·Ã Àå¾Ö¸¦ °¡Áø ÀþÀº ÃþÀÇ ¹ß´Þ ¹× ½É¸®Àû ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. ÀÎÁöÇൿġ·á(CBT), ³ëÃâ¹ÝÀÀ¿¹¹æ¹ý(ERP), °¡Á· Á᫐ Á¢±Ù¹ý µî Áõ°Å¿¡ ±â¹ÝÇÑ Ä¡·á¹ýÀ» äÅÃÇÏ¿© Á¢±ÙÀÌ ¿ëÀÌÇϰí ÀüÀÎÀûÀÎ Ä¡·á¸¦ º¸ÀåÇÕ´Ï´Ù. Á¾ÇÕÀûÀΠȸº¹À» ÃËÁøÇϱâ À§ÇØ ¸¶À½Ã¬±è, ½Åü °Ç°­, »ýȰ ±â¼ú ÈÆ·Ã ¹× Á¤½Å°Ç°­ Ä¡·á¸¦ ÅëÇÕÇÏ¿© Á¾ÇÕÀûÀΠȸº¹À» ÃËÁøÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½ºÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to alleviate anxiety. These behaviors often disrupt daily functioning and cause significant emotional distress. Common themes include concerns about cleanliness, orderliness, and fear of harm. Treatment generally involves a combination of therapy and medication.

The primary drug classes for OCD treatment include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), serotonin antagonist and reuptake inhibitors (SARIs), and tricyclic antidepressants (TCAs). SSRIs, a commonly prescribed class, function by increasing serotonin levels in the brain and preventing its reabsorption into nerve cells. These medications are also indicated for other conditions such as major depressive disorder, anxiety disorders, and attention deficit hyperactivity disorder (ADHD). The distribution channels for these drugs include hospital pharmacies, retail pharmacies, and other outlets, serving end users such as hospitals, specialty clinics, and other healthcare facilities.

The obsessive-compulsive disorder market research report is one of a series of new reports from The Business Research Company that provides obsessive-compulsive disorder market statistics, including obsessive-compulsive disorder industry global market size, regional shares, competitors with a obsessive-compulsive disorder market share, detailed obsessive-compulsive disorder market segments, market trends and opportunities, and any further data you may need to thrive in the obsessive-compulsive disorder industry. This obsessive-compulsive disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obsessive-compulsive disorder market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.64%. The growth during the historic period was driven by factors such as an increase in early diagnosis, a rising prevalence of mental health conditions, the expanded use of cognitive behavioral therapy (CBT), improved access to online therapy, and the development of personalized treatment plans.

The obsessive-compulsive disorder market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.38%. In the forecast period, growth is expected to be propelled by a rising prevalence of OCD, increasing demand for off-label drugs and therapies, heightened investment in the healthcare sector, growing awareness campaigns, and enhanced government initiatives. Key trends anticipated during this period include advancements in technology, the integration of digital health tools, the use of virtual reality in treatment, the expansion of telehealth services, and the continued adoption of cognitive behavioral therapy.

The increasing prevalence of mental illness is projected to drive growth in the obsessive-compulsive disorder (OCD) market. Mental illnesses encompass a broad spectrum of conditions that impact mood, thinking, behavior, and overall functioning. Their rise is attributed to greater awareness and diagnosis, lifestyle shifts, chronic stress, global crises, and escalating social, economic, and environmental pressures. OCD serves as a focal point for understanding the complexities of mental illnesses, advancing research, diagnosis, and treatment methods for various mental health conditions. For example, in September 2024, the National Institutes of Health (NIH) reported that in 2022, 59.3 million U.S. adults (23.1% of the population) experienced AMI (Any Mental Illness), with a higher prevalence among females (26.4%) compared to males (19.7%). This growing prevalence highlights the expanding demand for OCD-related treatments, boosting the market's growth.

Companies in the OCD market are innovating mental health treatment to deliver more effective therapeutic options. These treatments include a range of therapies, medications, and lifestyle interventions aimed at managing and alleviating mental health conditions. In October 2023, Newport Healthcare introduced a specialized OCD Treatment Program for teens and young adults. This initiative addresses the developmental and psychological needs of younger individuals with OCD and related disorders. By employing evidence-based therapies such as Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), and family-centered approaches, the program ensures accessible, holistic care. It integrates mental health treatment with mindfulness practices, physical wellness, and life skills training to promote comprehensive recovery.

In August 2023, Talkiatry partnered with NOCD to revolutionize OCD treatment through integrated services. This collaboration aims to enhance patient outcomes by combining NOCD's specialized ERP therapy with Talkiatry's psychiatric care expertise. NOCD, a U.S.-based mental health technology company, specializes in online therapy for OCD, making this partnership a strategic move to improve accessibility and streamline OCD care.

Major players in the obsessive-compulsive disorder market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Zydus Cadila, Amneal Pharmaceuticals Inc., Mallinckrodt plc, Lupin Pharmaceuticals Inc., Par Pharmaceutical, Biohaven Pharmaceuticals.

North America was the largest region in the obsessive-compulsive disorder market in 2024. The regions covered in obsessive-compulsive disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obsessive-compulsive disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obsessive-compulsive disorder market includes revenues earned by entities by providing services such as diagnosing, treating, and managing mental health conditions and related products including benzodiazepines, neurostimulation devices, and ERP therapy tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obsessive-Compulsive Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obsessive-compulsive disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for obsessive-compulsive disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obsessive-compulsive disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Obsessive-Compulsive Disorder Market Characteristics

3. Obsessive-Compulsive Disorder Market Trends And Strategies

4. Obsessive-Compulsive Disorder Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Obsessive-Compulsive Disorder Growth Analysis And Strategic Analysis Framework

6. Obsessive-Compulsive Disorder Market Segmentation

7. Obsessive-Compulsive Disorder Market Regional And Country Analysis

8. Asia-Pacific Obsessive-Compulsive Disorder Market

9. China Obsessive-Compulsive Disorder Market

10. India Obsessive-Compulsive Disorder Market

11. Japan Obsessive-Compulsive Disorder Market

12. Australia Obsessive-Compulsive Disorder Market

13. Indonesia Obsessive-Compulsive Disorder Market

14. South Korea Obsessive-Compulsive Disorder Market

15. Western Europe Obsessive-Compulsive Disorder Market

16. UK Obsessive-Compulsive Disorder Market

17. Germany Obsessive-Compulsive Disorder Market

18. France Obsessive-Compulsive Disorder Market

19. Italy Obsessive-Compulsive Disorder Market

20. Spain Obsessive-Compulsive Disorder Market

21. Eastern Europe Obsessive-Compulsive Disorder Market

22. Russia Obsessive-Compulsive Disorder Market

23. North America Obsessive-Compulsive Disorder Market

24. USA Obsessive-Compulsive Disorder Market

25. Canada Obsessive-Compulsive Disorder Market

26. South America Obsessive-Compulsive Disorder Market

27. Brazil Obsessive-Compulsive Disorder Market

28. Middle East Obsessive-Compulsive Disorder Market

29. Africa Obsessive-Compulsive Disorder Market

30. Obsessive-Compulsive Disorder Market Competitive Landscape And Company Profiles

31. Obsessive-Compulsive Disorder Market Other Major And Innovative Companies

32. Global Obsessive-Compulsive Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obsessive-Compulsive Disorder Market

34. Recent Developments In The Obsessive-Compulsive Disorder Market

35. Obsessive-Compulsive Disorder Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â